WorldHeart Announces First U.S. Implant of Levacor(TM) VAD Implant at INTEGRIS in Oklahoma City

SALT LAKE CITY, Jan 19, 2010 /PRNewswire via COMTEX/ -- World Heart Corporation ("WorldHeart") (Nasdaq: WHRT), a developer of mechanical circulatory systems, announced today that the first U.S. implant of the Levacor Ventricular Assist Device ("VAD") was successfully performed at INTEGRIS Baptist Medical Center ("INTEGRIS") in Oklahoma City on Wednesday, January 13, 2010.

This is the first implant in the Levacor VAD bridge-to-transplant ("BTT") study, which is expected to enroll 160 patients, pursuant to a recently approved U.S. Investigational Device Exemption Application. INTEGRIS is the first of the initial ten BTT clinical study sites.

Read full release here.

Global Administrator | 1/19/2010 9:24:33 AM | 0 Comments